Deepinder Goyal has revealed fresh research on Temple, his wearable device designed to track changes in blood flow around the brain, as the company gets closer to a broader launch in India. The latest study indicates that Temple BrainFlow showed a stronger relationship with changes in blood volume in the brain than with changes occurring in the scalp.
The findings are from a second validation study involving Temple BrainFlow and time-domain near-infrared spectroscopy (TD-NIRS), a method capable of separating signals originating from deeper brain tissue from those coming from the superficial layers of the scalp. According to the preprint shared by Goyal, researchers examined 60 sessions involving 44 healthy young adult men. The participants underwent three controlled physiological tests: a 30-degree head-down tilt, transitioning from standing to a squat, and moving from standing to a lying-down position.
Deepinder Goyal reveals more details about Temple on X.
The researchers compared Temple's Brain Flow Index with changes in blood volume recorded in the brain and scalp layers through TD-NIRS. Across the three experiments, the median correlation between Temple BrainFlow and the model-derived brain signal stood at 0.912 during the head-down tilt, 0.843 during the stand-to-squat movement and 0.839 during the stand-to-supine transition.
The corresponding correlations for scalp signals were lower, at 0.494, 0.700 and 0.767, respectively. Goyal said the findings indicate that “Temple tracks the brain, much more than the scalp.” He highlighted the head-down tilt experiment in particular, where the correlation with the brain signal was 0.91, compared with 0.49 for the scalp signal.
The study found that the difference between the brain and scalp measurements was statistically significant during the head-down tilt and stand-to-squat tests. However, the difference was not statistically significant during the stand-to-supine transition.
According to Goyal, cerebral blood flow could help researchers understand how the body responds to conditions and activities including exercise, sleep, dehydration and extended periods of sitting. He said Temple is intended to continuously monitor these changes rather than measuring them only during controlled clinical tests.
The research was conducted under the guidance of David Boas, director of Boston University's Neurophotonics Center and a scientific adviser to Temple. Goyal said this marks the second modality against which Temple BrainFlow has been validated, following Transcranial Doppler.
However, the research is currently available only as a preprint and has not yet undergone peer review. The paper also notes that Temple Private Limited funded and conducted the research, while several of the authors are employees of the company or have other research connections with it. The researchers added that additional studies using flow-sensitive reference methods and more comprehensive systemic monitoring will be required to establish cerebral specificity.
Temple India launch date?
A confirmed public date for Temple's broader launch in India has not yet been announced. Goyal had earlier said that the limited launch edition would start shipping before the end of 2026. He has now suggested that the company may announce a pre-order date soon, saying it is waiting for clarity on a couple of outstanding issues.
